Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium
- PMID: 35879765
- PMCID: PMC9310674
- DOI: 10.1186/s13054-022-04086-x
Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium
Abstract
Background: Acute kidney injury (AKI) has been reported as a frequent complication of critical COVID-19. We aimed to evaluate the occurrence of AKI and use of kidney replacement therapy (KRT) in critical COVID-19, to assess patient and kidney outcomes and risk factors for AKI and differences in outcome when the diagnosis of AKI is based on urine output (UO) or on serum creatinine (sCr).
Methods: Multicenter, retrospective cohort analysis of patients with critical COVID-19 in seven large hospitals in Belgium. AKI was defined according to KDIGO within 21 days after ICU admission. Multivariable logistic regression analysis was used to explore the risk factors for developing AKI and to assess the association between AKI and ICU mortality.
Results: Of 1286 patients, 85.1% had AKI, and KRT was used in 9.8%. Older age, obesity, a higher APACHE II score and use of mechanical ventilation at day 1 of ICU stay were associated with an increased risk for AKI. After multivariable adjustment, all AKI stages were associated with ICU mortality. AKI was based on sCr in 40.1% and UO in 81.5% of patients. All AKI stages based on sCr and AKI stage 3 based on UO were associated with ICU mortality. Persistent AKI was present in 88.6% and acute kidney disease (AKD) in 87.6%. Rapid reversal of AKI yielded a better prognosis compared to persistent AKI and AKD. Kidney recovery was observed in 47.4% of surviving AKI patients.
Conclusions: Over 80% of critically ill COVID-19 patients had AKI. This was driven by the high occurrence rate of AKI defined by UO criteria. All AKI stages were associated with mortality (NCT04997915).
Keywords: Acute kidney injury; COVID-19; Epidemiology; Intensive care unit; KDIGO; Kidney replacement therapy; Mortality; Renal replacement therapy; Serum creatinine; Urine output.
© 2022. The Author(s).
Conflict of interest statement
EH received Speakers fees from Alexion, Sopachem and Astute Medical paid to the institution and a travel grant from AM Pharma. All other authors declare no conflicts of interest.
Figures



Similar articles
-
Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.Am J Kidney Dis. 2022 Mar;79(3):404-416.e1. doi: 10.1053/j.ajkd.2021.11.004. Epub 2021 Dec 4. Am J Kidney Dis. 2022. PMID: 34871701 Free PMC article.
-
Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.BMC Nephrol. 2021 Mar 15;22(1):92. doi: 10.1186/s12882-021-02296-z. BMC Nephrol. 2021. PMID: 33722189 Free PMC article.
-
Early acute kidney injury is associated with in-hospital adverse outcomes in critically ill burn patients: an observational study.Nephrol Dial Transplant. 2023 Aug 31;38(9):2002-2008. doi: 10.1093/ndt/gfac339. Nephrol Dial Transplant. 2023. PMID: 36564032
-
Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria.BMC Nephrol. 2017 Feb 20;18(1):70. doi: 10.1186/s12882-017-0487-8. BMC Nephrol. 2017. PMID: 28219327 Free PMC article. Review.
-
Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis.Crit Care. 2020 Jan 2;24(1):2. doi: 10.1186/s13054-019-2710-4. Crit Care. 2020. PMID: 31898523 Free PMC article.
Cited by
-
SARS-CoV-2 PCR cycle threshold value at admission might not be a good predictor of in-hospital COVID-19-associated AKI.J Gen Fam Med. 2024 Apr 5;25(4):179-186. doi: 10.1002/jgf2.682. eCollection 2024 Jul. J Gen Fam Med. 2024. PMID: 38966657 Free PMC article.
-
Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients.Infect Dis Rep. 2024 May 16;16(3):458-471. doi: 10.3390/idr16030034. Infect Dis Rep. 2024. PMID: 38804444 Free PMC article.
-
Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury.Front Pharmacol. 2024 Jan 3;14:1333389. doi: 10.3389/fphar.2023.1333389. eCollection 2023. Front Pharmacol. 2024. PMID: 38239193 Free PMC article.
-
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.Sci Rep. 2023 May 13;13(1):7804. doi: 10.1038/s41598-023-34613-x. Sci Rep. 2023. PMID: 37179397 Free PMC article. Review.
-
The Effects of TRPC6 Knockout in Animal Models of Kidney Disease.Biomolecules. 2022 Nov 18;12(11):1710. doi: 10.3390/biom12111710. Biomolecules. 2022. PMID: 36421724 Free PMC article. Review.
References
-
- Panel C-TG. National Institute of Health; 2021. https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treat...
-
- COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center; 2021. https://coronavirus.jhu.edu/map.html
-
- Bayrakci N, Ozkan G, Sakaci M, Sedef S, Erdem I, Tuna N, et al. The incidence of acute kidney injury and its association with mortality in patients diagnosed with COVID-19 followed up in intensive care unit. Ther apheresis Dial Off Peer-Rev J Int Soc Apheresis Jpn Soc Apheresis Jpn Soc Dial Ther. 2022 doi: 10.1111/1744-9987.13790. - DOI - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials